Weiss Multi-Strategy Advisers’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,713	Closed	-$364K	–	805
2021 Q3	$364K	Buy	10,713 +233	+2%	+$7.44K	0.01%	587
2021 Q2	$384K	Buy	10,480 +374	+4%	+$14.5K	0.01%	581
2021 Q1	$453K	Sell	10,106 -413	-4%	-$19.2K	0.01%	552
2020 Q4	$600K	Sell	10,519 -730	-6%	-$43.3K	0.01%	545
2020 Q3	$577K	Buy	11,249 +5,981	+114%	+$293K	0.02%	466
2020 Q2	$315K	Sell	5,268 -1,142	-18%	-$61.1K	0.01%	494
2020 Q1	$264K	Buy	+6,410	New	+$356K	0.01%	378
2017 Q4	–	Sell	-85,000	Closed	-$1.61M	–	684
2017 Q3	$1.61M	Buy	+85,000	New	+$1.56M	0.06%	333

Other funds holding DCPH

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Weiss Multi-Strategy Advisers's DCPH Position: Q4 2021 in Review

Weiss Multi-Strategy Advisers sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 10,713 shares — an estimated $364K sold.

Weiss Multi-Strategy Advisers first reported a position in DCPH in Q3 2017 and held it in 8 quarters. The position peaked at $1.61M in Q3 2017. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

Weiss Multi-Strategy Advisers reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 10,713 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $364K.
Weiss Multi-Strategy Advisers first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 8 quarters.
Weiss Multi-Strategy Advisers's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.61M in Q3 2017.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.